Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
BMC Medical Education|March 31, 2007
Assessing medical students' attitudes towards learning communication skills--which components of attitudes do we measure?Tor Anvik, Tore Gude, Hilde Grimstad, et al.Medical Teacher|May 20, 2008
Medical students' cognitive and affective attitudes towards learning and using communication skills--a nationwide cross-sectional studyTor Anvik, Hilde Grimstad, Anders Baerheim, et al.Breast Cancer Research : BCR|March 17, 2012
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancerStian Knappskog, Ranjan Chrisanthar, Erik Løkkevik, et al.BMC Cancer|December 25, 2012
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyMarit Synnestvedt, Elin Borgen, Erik Wist, et al.Breast Cancer Research : BCR|August 15, 2012
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survivalRandi R Mathiesen, Elin Borgen, Anne Renolen, et al.Plos One|August 30, 2008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancerRanjan Chrisanthar, Stian Knappskog, Erik Løkkevik, et al.BMC Cancer|June 16, 2018
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypesTrygve Lofterød, Elin S Mortensen, Hawa Nalwoga, et al.Plos One|May 11, 2011
Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxelRanjan Chrisanthar, Stian Knappskog, Erik Løkkevik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancerBjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancerVidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, et al.Pageof 3